4 Ways to Invest in Healthcare Stocks
In January 2019, Frost & Sullivan predicted that the global healthcare market is likely to grow by 5.1% in 2019 and would cross the $1.96 trillion mark in manufacturer revenues by the end of the year, which could impact healthcare stocks.
Frost & Sullivan, in their yearly Transformational Health report, stated that this growth is expected to be driven by advancements in technology platform solutions that lead to innovation in healthcare and chronic disease management, as well as through the emerging markets.
In fact, Deloitte's 2019 Global Health Care Outlook report reveals that global healthcare spend is likely to increase at an annual rate of 5.4% between 2017-2022, from USD $7.724 trillion to USD $10.059 trillion.
All of these statistics certainly make investing in healthcare stocks seem like a good idea. Add to that the fact that Charles Schwab gave an 'Outperform' rating to this sector on September 27, 2018, and medical stocks seem to be becoming even more attractive.
In fact, healthcare stocks rank third after the technology and finance sector in the S&P 500 index. However, even for a sector that appears extremely appealing, it's important to make informed investment decisions using the right analytical tools, and remain updated with the latest news and economic announcements within the sector.
If you are interested in investing in healthcare stocks, you're in the right place. Let's dive in!
In this article, I'm going to cover:
This really is a large sector that goes far beyond hospitals and pharma companies. Here's a look at the various types of companies you can choose from when searching for the best healthcare dividend stocks.
Pharmaceutical companies produce almost all over-the-counter (OTC) and prescription drugs. Large pharmaceutical firms are usually less risky to invest in, as compared with their younger or smaller counterparts. These companies spend a major portion of their resources on R&D (Research & Development), to bring innovative treatments to the market.
So, if a company releases a new drug with huge earning potential, its stock will perform well. You may find a small group of healthcare shares collectively called "Big Pharma," which consists of the large-cap pharma companies. However, even when investing in 'Big Pharma', you should have knowledge concerning:
- The scope of the drugs
- The scale of the people affected by the disease the drug addresses
- The availability of substitutes and drugs by competitors
- Intellectual property rights related to the process of manufacturing and the drug's patent
- Profit and revenue division pacts with other companies
The clinical trials conducted before a drug is launched, and their outcomes, also affect share prices in the healthcare segment. Positive outcomes tend to drive prices up, while negative outcomes could even potentially lead to a crash. Investment in pharma companies, therefore, requires active analysis by investors.
Hospitals and clinics are the foundation of any healthcare system. Therefore, when their stock is available for investment in, they do tend to offer good investment potential. Here, too, the larger companies, such as Acadia healthcare stock, would offer more stable potential and lesser risk. Of course, risk is always a part of any investment, and using good risk management strategies is vital.
Healthcare service providers are subject to enormous regulatory risks. Hospitals often make quick and costly hardware, and software changes for better facilities, and to attract more patients. This might, however, make the hospitals prone to bad debt, and may also affect their dividends.
Medical insurance firms are also an important player in the healthcare services sector. They pay the bills, so, the better the underwriting, the lower the medical costs incurred by the insurance company will be.
This is why it's important to analyse the medical cost ratio, and medical loss ratio before investing in such healthcare sector stocks. The insurance industry is also highly volatile, due to changes that take place in the regulatory framework. However, their stocks tend to be less volatile than hospital stocks. You need to keep an active eye on the regulatory framework to minimise losses associated with these stocks.
Medical Device Stocks
With increasing life expectancy, medical devices are becoming more important than ever before. Medical device firms generally witness a slow growth rate. The products offered by them range from bandages to artificial joints, and from digital blood pressure monitors to heart stents, and much more. Such devices will always be in demand, but an instant boom of any specific device is unlikely.
These firms, also spend a large share of their resources on R&D, as well as the stages after R&D. Here, there are older, more stable firms, as well as small startups with great potential for growth. Healthcare software providers offer greater potential for growth than hardware manufacturers. Today, hospitals worldwide are adopting automated systems to offer better services to patients.
On the other hand, advances in technology are bringing AI and robotics into the healthcare system, changing the way medical care is provided. You need to study the technology, the substitute products, and the competitors of a firm before investing. Adoption rates and gross margins typically determine the success of these healthcare technology stocks.
Investment in biotechnology stocks is generally considered high yielding, although it does entail risks as well. You may also consider investing in stocks of companies that are involved in R&D for the treatment of chronic and terminal ailments, such as cancer, AIDS, diabetes, heart disease, neurological diseases, immunological diseases, viral infections, stem cell and tissue regeneration.
If these projects are successful, they will greatly impact the lives of people worldwide, which in turn would drive up the share price. You might even consider investing in companies with a strong network of collaborative support, indicating that it is financially and logistically stable.
Biotech stocks nearing the end of their R&D stage, or awaiting approval from the regulatory authorities are also likely to be better investment options. However, remember that if the clinical trial fails to produce the desired outcome or there are regulatory hurdles, the share price might decline.
List of Major Stocks
Here I'll provide a list of major heal care companies offering shares:
The company '1Life' does business under the name One Medical. It's a chain of primary healthcare clinics based in San Francisco. It is a membership-based service with both in-person care services and online resources. Online resources include a mobile app.
One Medical's founder is Tom Lee, who started the company in 2007. It grew from one San Francisco clinic to over 72 locations all across the USA. These include 29 clinics in the San Francisco Bay Area.
In 2017, Amir Rubin became CEO of the company and in 2018, The Carlyle Group invested $350 million into One Medical. They are also backed by Google's parent company Alphabet Inc.
On January 31, 2020, One Medical started trading shares in their company on the Nasdaq stock exchange.
The company, 'Acadia Healthcare' is a behavioural healthcare provider operating internationally. It has a network of more than 584 locations throughout the United Kingdom, United States and Puerto Rico. Acadia focuses on providing addiction and behavioural health services in various settings.
These include residential treatment clinics, inpatient psychiatric hospitals, outpatient clinics and school-based programs offering therapeutic services. Acadia was created in January 2005, and has headquarters in Franklin, Tennessee.
Other major healthcare stocks include:
- Allied healthcare stock
- AMN healthcare stock
- Andlauer healthcare group stock
- GE healthcare stock
- Genesis healthcare stock
- HCA healthcare stock
- Molina healthcare stock
- Omega healthcare stock
- Ryman healthcare stock
- Tenet healthcare stock
- United healthcare stock
These are some large healthcare-related companies offering shares.
Are you ready to start trading already? If you want to experience a real trading environment, but without risking any money, you can sign up for a free demo account with Admiral Markets by clicking the banner below. Yep, zero-risk trading with real market data:
A 3-Way Investment Solution for the Healthcare Sector
Big Pharma Companies
Investing in companies with large market capitalisation tends to be less risky. They don't offer explosive growth, but they do have stability.
Healthcare Real Estate
With increasing demand for healthcare, there will also be a need for more hospitals, labs, and clinics to meet the demand. Healthcare real estate investment trusts (REITs), therefore, prove to be a viable option for investment. However, remember to research the credit ratings of the REITs before investing in one.
Some examples of REITs include:
- Alstria Office REIT-AG CFD (AOX)
- Hamborner REIT AG CFD (HAB)
- Tritax Big Box REIT Plc CFD (BBOX)
If you are unsure about investing in individual health care stocks, you could also consider investing in healthcare ETFs. Healthcare ETFs are designed to track the performance of the healthcare sector, and provide an easy way to gain exposure to the sector, without having to know much about the individual companies.
ETFs include health insurance and managed-care companies, along with associated businesses, such as pharmacy benefits management, and treatment providers.
Here are some examples of healthcare ETF CFDs:
- iShares Global Healthcare ETF CFD (IXJ)
- iShares U.S. Healthcare ETF CFD (IYH)
- iShares U.S. Healthcare Providers ETF CFD (IHF)
Diversification is important for any investment portfolio, and healthcare offers great potential in this regard. Investing in healthcare shares can provide good returns, but it also has various risks attached to it. This sector offers a number of options and sub-sectors to choose from for your investment, so picking the right investment instrument is the first step to success.
Other articles that might interest you:
- How to Start Commodities Trading: A beginner's guide to commodities
- Overview of the Best Metatrader Indicators
About Admiral Markets
Admiral Markets is a multi-award winning, globally regulated Forex and CFD broker, offering trading on over 8,000 financial instruments via the world's most popular trading platforms: MetaTrader 4 and MetaTrader 5. Start trading today!
The given data provides additional information regarding all analysis, estimates, prognosis, forecasts, market reviews, weekly outlooks or other similar assessments or information (hereinafter “Analysis”) published on the websites of Admiral Markets investment firms operating under the Admiral Markets trademark (hereinafter “Admiral Markets”) Before making any investment decisions please pay close attention to the following:
- This is a marketing communication. The content is published for informative purposes only and is in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
- Any investment decision is made by each client alone whereas Admiral Markets shall not be responsible for any loss or damage arising from any such decision, whether or not based on the content.
- With view to protecting the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.
- The Analysis is prepared by an independent analyst, Boris Petrov (Financial Analyst), (hereinafter “Author”) based on their personal estimations.
- Whilst every reasonable effort is taken to ensure that all sources of the content are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis.
- Any kind of past or modeled performance of financial instruments indicated within the content should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
- Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, please ensure that you fully understand the risks involved.